🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Joshua J. Gagne

ORCID: 0000-0001-5428-9733
Economics, Econometrics and FinanceMathematicsPharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile
0.104Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Prospective validation of a dynamic prognostic model for identifying COVID‐19 patients at high risk of rapid deterioration

Pharmacoepidemiology and Drug Safety(2022)10.1002/pds.5580
Top 78%
0.104DataRank
Top 78%1 citations

Elvira D’Andrea, Rishi Desai, Joshua J. Gagne, Jun S. Liu, Shirley Wang +1 more

Papers

Driven by 7 papers — median percentile 22. Top paper: “Longitudinal Data Discontinuity in Electronic Health Records and Consequences for Medication Effectiveness Studies”.

Longitudinal Data Discontinuity in Electronic Health Records and Consequences for Medication Effectiveness Studies

Clinical Pharmacology & Therapeutics(2021)10.1002/cpt.2400
N/A
0.464DataRank · unranked
21 citations

Yinzhu Jin, Joshua J. Gagne, Robert J. Glynn, Shawn N. Murphy, Angela Tong +2 more

Prospective validation of a dynamic prognostic model for identifying COVID‐19 patients at high risk of rapid deterioration

Pharmacoepidemiology and Drug Safety(2022)10.1002/pds.5580
Top 78%
0.104DataRank
Top 78%1 citations

Elvira D’Andrea, Rishi Desai, Joshua J. Gagne, Jun S. Liu, Shirley Wang +1 more

Disease risk score as a confounder summary method: systematic review and recommendations: DRS AS A CONFOUNDER SUMMARY METHOD

UNC Libraries(2020)10.17615/6z3g-4q88
N/A
0DataRank · unranked
0 citations

Mina Tadrous, Suzanne M. Cadarette, Joshua J. Gagne, Til Stürmer‎

The risk of sudden cardiac arrest and ventricular arrhythmia with rosiglitazone versus pioglitazone: real-world evidence on thiazolidinedione safety

Cardiovascular Diabetology(2020)10.1186/s12933-020-00999-5
N/A
0DataRank · unranked
19 citations

Colleen Brensinger, Ghadeer K. Dawwas, Rajat Deo, Warren B. Bilker, Samantha E. Soprano +8 more

Evaluation of Drug–Drug Interactions in Pharmacoepidemiologic Research

Pharmacoepidemiology and Drug Safety(2025)10.1002/pds.70088
N/A
0DataRank · unranked
13 citations

Thanh Phuong Pham Nguyen, John E. Hughes, Sean Hennessy, Charles E. Leonard, Todd A. Miano +4 more

Confounder summary scores when comparing the effects of multiple drug exposures

UNC Libraries(2020)10.17615/8qk3-gs19
N/A
0DataRank · unranked
0 citations

Til Stà ⁄ rmer, Jeffrey N. Katz, Suzanne M. Cadarette, Daniel H. Solomon, Joshua J. Gagne

Comparison of a new 3-item self-reported measure of adherence to medication with pharmacy claims data in patients with cardiometabolic disease

American Heart Journal(2020)10.1016/j.ahj.2020.06.012
N/A
0DataRank · unranked
27 citations

Constance P. Fontanet, Thomas Isaac, Chandrasekar Gopalakrishnan, Thomas D. Sequist, Joshua J. Gagne +5 more